Bioengineering in the oral cavity: our experience

L Catalfamo,1 E Belli,2 C Nava,1 E Mici,1 A Calvo,1 B D'Alessandro,1 FS De Ponte1 1Unit of Maxillofacial Surgery, University of Messina, Azienda Ospedaliera Universitaria, Policlinico G Martino, Messina, Italy; 2Unit of Maxillofacial Surgery, University Rome Sapienza, Azienda Ospedaliera San...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Catalfamo L, Belli E, Nava C, Mici E, Calvo A, D'Alessandro B, De Ponte FS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/25166486d3ef4f5d826ec66ac6cd26bd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:25166486d3ef4f5d826ec66ac6cd26bd
record_format dspace
spelling oai:doaj.org-article:25166486d3ef4f5d826ec66ac6cd26bd2021-12-02T07:22:51ZBioengineering in the oral cavity: our experience1176-91141178-2013https://doaj.org/article/25166486d3ef4f5d826ec66ac6cd26bd2013-10-01T00:00:00Zhttp://www.dovepress.com/bioengineering-in-the-oral-cavity-our-experience-a14632https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013L Catalfamo,1 E Belli,2 C Nava,1 E Mici,1 A Calvo,1 B D'Alessandro,1 FS De Ponte1 1Unit of Maxillofacial Surgery, University of Messina, Azienda Ospedaliera Universitaria, Policlinico G Martino, Messina, Italy; 2Unit of Maxillofacial Surgery, University Rome Sapienza, Azienda Ospedaliera Sant Andrea, Rome, Italy Background: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and synthetic hyaluronic acid medications to improve wound healing in the oral cavity by stimulating granulomatous tissue. Methods: From 2007 to 2011, 80 patients (median age 67 years) suffering from oral mucosal lesions participated in this double-blind study. The patients were divided into two groups, each consisting of 40 patients. One group received conventional medications, while the other group of patients were treated with the advanced medications. Results: Advanced medications allowed re-epithelialization of the wound margin in 2–20 days, whereas patients receiving conventional medication showed a median healing duration of 45 days. Conclusion: The results of this study demonstrate that treating oral mucosal wounds with advanced medication has an advantage with regard to wound healing time, allowing patients to have a rapid, functional, and esthetic recovery. Keywords: bioengineering, oral cavity, mucosal recoveryCatalfamo LBelli ENava CMici ECalvo AD'Alessandro BDe Ponte FSDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss Issue 1, Pp 3883-3886 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Catalfamo L
Belli E
Nava C
Mici E
Calvo A
D'Alessandro B
De Ponte FS
Bioengineering in the oral cavity: our experience
description L Catalfamo,1 E Belli,2 C Nava,1 E Mici,1 A Calvo,1 B D'Alessandro,1 FS De Ponte1 1Unit of Maxillofacial Surgery, University of Messina, Azienda Ospedaliera Universitaria, Policlinico G Martino, Messina, Italy; 2Unit of Maxillofacial Surgery, University Rome Sapienza, Azienda Ospedaliera Sant Andrea, Rome, Italy Background: To date, there are no studies reported in the literature on the possible use of bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in the oral cavity. The aim of this paper is to report the use of bovine collagen, oxidized regenerated cellulose, and synthetic hyaluronic acid medications to improve wound healing in the oral cavity by stimulating granulomatous tissue. Methods: From 2007 to 2011, 80 patients (median age 67 years) suffering from oral mucosal lesions participated in this double-blind study. The patients were divided into two groups, each consisting of 40 patients. One group received conventional medications, while the other group of patients were treated with the advanced medications. Results: Advanced medications allowed re-epithelialization of the wound margin in 2–20 days, whereas patients receiving conventional medication showed a median healing duration of 45 days. Conclusion: The results of this study demonstrate that treating oral mucosal wounds with advanced medication has an advantage with regard to wound healing time, allowing patients to have a rapid, functional, and esthetic recovery. Keywords: bioengineering, oral cavity, mucosal recovery
format article
author Catalfamo L
Belli E
Nava C
Mici E
Calvo A
D'Alessandro B
De Ponte FS
author_facet Catalfamo L
Belli E
Nava C
Mici E
Calvo A
D'Alessandro B
De Ponte FS
author_sort Catalfamo L
title Bioengineering in the oral cavity: our experience
title_short Bioengineering in the oral cavity: our experience
title_full Bioengineering in the oral cavity: our experience
title_fullStr Bioengineering in the oral cavity: our experience
title_full_unstemmed Bioengineering in the oral cavity: our experience
title_sort bioengineering in the oral cavity: our experience
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/25166486d3ef4f5d826ec66ac6cd26bd
work_keys_str_mv AT catalfamol bioengineeringintheoralcavityourexperience
AT bellie bioengineeringintheoralcavityourexperience
AT navac bioengineeringintheoralcavityourexperience
AT micie bioengineeringintheoralcavityourexperience
AT calvoa bioengineeringintheoralcavityourexperience
AT damp39alessandrob bioengineeringintheoralcavityourexperience
AT depontefs bioengineeringintheoralcavityourexperience
_version_ 1718399446126952448